tyrosine has been researched along with Myasthenia Gravis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Santilli, A; Stitt, D | 1 |
| Blackmore, D; Li, L; Maksymowych, W; Siddiqi, ZA; Wang, N; Yacyshyn, E | 1 |
| Assini, A; Damato, V; Del Sette, M; Evoli, A; Gandoglia, I; Rikani, K | 1 |
| Abe, K; Deguchi, K; Deguchi, S; Hishikawa, N; Kono, S; Matsuzono, K; Motomura, M; Nakano, Y; Ohta, K; Ota, Y; Sato, K; Tanabe, K; Yamashita, T | 1 |
| Basta, I; Lavrnic, D; Nikolic, A; Peric, S; Stankovic, M; Stankovic, T; Stojiljkovic Tamas, O | 1 |
| Fujita, Y; Furuta, N; Ikeda, M; Ikeda, Y; Ishizawa, K; Makioka, K; Motomura, M; Nagamine, S; Okamoto, K; Shibata, M; Tsukagoshi, S; Yoshimura, S | 1 |
| Adamczyk-Sowa, M; Bartosz, G; Bieszczad-Bedrejczuk, E; Czyżewski, D; Galiniak, S; Rozmiłowska, I; Sadowska-Bartosz, I | 1 |
| Martin-Du Pan, RC; Wurtman, RJ | 1 |
| Baez, S; Jimenez, V; John, E; Lechin, F; Lechin, ME; Orozco, B; Pardey-Maldonado, B; van der Dijs, B | 1 |
2 review(s) available for tyrosine and Myasthenia Gravis
| Article | Year |
|---|---|
MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.
Topics: Autoantibodies; Female; Humans; Middle Aged; Myasthenia Gravis; Paresis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Tyrosine; Vocal Cords | 2021 |
[The role of nutrition in the synthesis of neurotransmitters and in cerebral functions: clinical implications].
Topics: Alzheimer Disease; Amino Acids; Choline; Choline O-Acetyltransferase; Diabetes Mellitus; Dopa Decarboxylase; Humans; Intellectual Disability; Memory; Myasthenia Gravis; Neurotransmitter Agents; Nutritional Physiological Phenomena; Serotonin; Tryptophan; Tyrosine | 1981 |
1 trial(s) available for tyrosine and Myasthenia Gravis
| Article | Year |
|---|---|
Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Aged; Benzhydryl Compounds; Buspirone; Desipramine; Drug Therapy, Combination; Electromyography; Epinephrine; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Modafinil; Myasthenia Gravis; Neuroprotective Agents; Neurotransmitter Agents; Norepinephrine; Phenylalanine; Platelet Aggregation; Propranolol; Serotonin; Serotonin Receptor Agonists; Sympathetic Nervous System; Tyrosine | 2000 |
6 other study(ies) available for tyrosine and Myasthenia Gravis
| Article | Year |
|---|---|
Metabolomic profile overlap in prototypical autoimmune humoral disease: a comparison of myasthenia gravis and rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Female; Humans; Male; Metabolic Networks and Pathways; Metabolome; Middle Aged; Myasthenia Gravis; Phenylalanine; Pyruvic Acid; Tyrosine; Ubiquinone | 2020 |
Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection.
Topics: Aged; Autoantibodies; COVID-19; Humans; Male; Myasthenia Gravis; Receptors, Cholinergic; SARS-CoV-2; Tyrosine | 2021 |
Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
Topics: Adult; Ambulatory Care; Autoantibodies; Deglutition Disorders; Humans; Immunoglobulins, Intravenous; Male; Muscle Weakness; Myasthenia Gravis; Plasma Exchange; Plasmapheresis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Tyrosine | 2018 |
Quality of life in patients with MuSK positive myasthenia gravis.
Topics: Autoantibodies; Environment; Female; Humans; Male; Myasthenia Gravis; Quality of Life; Receptor Protein-Tyrosine Kinases; Treatment Outcome; Tyrosine | 2018 |
Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Autoantibodies; Biomarkers; Deglutition Disorders; Disease Progression; Drug Administration Schedule; Female; Glucocorticoids; Humans; Middle Aged; Myasthenia Gravis; Prednisolone; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome; Tyrosine | 2015 |
Oxidative modifications of blood serum proteins in myasthenia gravis.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Aged, 80 and over; Autoantibodies; Benzothiazoles; Blood Proteins; Disease Progression; Female; Glycophorins; Humans; Kynurenine; Male; Middle Aged; Myasthenia Gravis; Oxidative Stress; Protein Carbonylation; Receptors, Cholinergic; Sulfonic Acids; Thymectomy; Tyrosine | 2017 |